Shandong Xinhua Pharmaceutical Company Limited
Simbol: 000756.SZ
SHZ
16.15
CNYTržna cena danes
22.4147
Razmerje P/E
2.9139
Razmerje PEG
8.86B
Kapaciteta MRK
- 0.01%
Donos DIV
Shandong Xinhua Pharmaceutical Company Limited (000756-SZ) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 3643.84 | 918.3 | 1158.7 | 744.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | -137.64 | 0 | -48.4 | -56.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 4745.26 | 1017.1 | 1035.4 | 937.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.inventory | 4427.67 | 1313 | 1212 | 1027.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 237.57 | 65.9 | 50.8 | 44.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 13054.34 | 3314.3 | 3457 | 2754 | ||||||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 16128.64 | 4082.6 | 4000.5 | 3765.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 1913.47 | 494.9 | 474.1 | 466.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1913.47 | 494.9 | 474.1 | 466.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 1176.32 | 275.3 | 287.5 | 316.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 153.72 | 91.6 | 16 | 15.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 393.23 | 95.6 | 30.1 | 14.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 19765.37 | 5040 | 4808.2 | 4578.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-assets | 32819.72 | 8354.3 | 8265.1 | 7332 | ||||||||||||||||||||||||||||||
balance-sheet.row.account-payables | 3935.84 | 666.4 | 1090.1 | 1066.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 2671.86 | 1073.2 | 835.5 | 693.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 102.71 | 5 | 33.7 | 28.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 3207.47 | 799.4 | 548.4 | 350.5 | ||||||||||||||||||||||||||||||
Deferred Revenue Non Current | 411.66 | 100.7 | 118.4 | 132.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 490.44 | - | - | - | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 636.64 | 597.3 | 639.7 | 45.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 4086.23 | 971.9 | 756.7 | 1179 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 7.07 | 1.6 | 2.7 | 4.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liab | 13681.05 | 3457.9 | 3915.2 | 3680.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.common-stock | 2706.46 | 674.7 | 669.6 | 627.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 9120.77 | 2305.4 | 1988.1 | 1709.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 4793.33 | 819.2 | 744.7 | 647.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1507.66 | 753.8 | 724.1 | 484.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 18128.21 | 4553.1 | 4126.5 | 3467.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 32819.72 | 8354.3 | 8265.1 | 7332 | ||||||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 889.79 | 222.6 | 223.4 | 183.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-equity | 19018 | 4775.8 | 4349.9 | 3651.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 32819.72 | - | - | - | ||||||||||||||||||||||||||||||
Total Investments | 1038.68 | 275.3 | 239.2 | 260.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-debt | 5880.91 | 1874.2 | 1383.9 | 1043.8 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-debt | 2237.07 | 955.8 | 225.1 | 299.1 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 486.79 | 496.5 | 426.3 | 362.1 | ||||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 5.33 | 520.3 | 484.8 | 434.3 | ||||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 577.52 | 6 | 20 | 13.7 | ||||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 80.43 | -1917.3 | 46.4 | 4 | ||||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -491.34 | -876.8 | -265.4 | -539.6 | ||||||||||||||||||||||||||
cash-flows.row.account-receivables | -423.54 | -423.5 | -717.3 | -751.1 | ||||||||||||||||||||||||||
cash-flows.row.inventory | -120.86 | -120.9 | -200.1 | 76.2 | ||||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -332.4 | 632.1 | 121.6 | ||||||||||||||||||||||||||
cash-flows.row.other-working-capital | 53.07 | 0 | 20 | 13.7 | ||||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | -144.29 | 2044.7 | 46.1 | -15.4 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 487.09 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -321.28 | -325.1 | -244.8 | -249.2 | ||||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 11.27 | 11.9 | 45.3 | 19.8 | ||||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -9.94 | 0 | -45.3 | -19.8 | ||||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 3.07 | 8.2 | 7.9 | 9.1 | ||||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 15.04 | -8.2 | 7.9 | 2.4 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -301.84 | -313.3 | -228.9 | -237.7 | ||||||||||||||||||||||||||
cash-flows.row.debt-repayment | -572.67 | -25.7 | -888.7 | -559.7 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.dividends-paid | -173.23 | -134.9 | -163 | -148.4 | ||||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 758.03 | -35.5 | 921 | 568.4 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -122.9 | -196.1 | -130.7 | -139.7 | ||||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 12.4 | 6.9 | 15.7 | -7.9 | ||||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 88.83 | -240.4 | 414.4 | -126.2 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 3262.6 | 918.3 | 1010.8 | 596.4 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 3173.78 | 1158.7 | 596.4 | 722.6 | ||||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 487.09 | 273.4 | 758.2 | 259.1 | ||||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -321.28 | -325.1 | -244.8 | -249.2 | ||||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 165.81 | -51.7 | 513.5 | 9.9 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 7922.31 | 8008.7 | 7503 | 6560.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 5715.98 | 5800.2 | 5465.7 | 4786.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 2206.33 | 2208.5 | 2037.3 | 1773.7 | ||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
income-statement-row.row.research-development | 449.03 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 139.5 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 718.33 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.other-expenses | -26.24 | -63.4 | 333.4 | 244.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 1663.48 | 1696 | 1493.9 | 1274.7 | ||||||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 7379.46 | 7496.3 | 6959.6 | 6061.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-income | 13.12 | 12.3 | 10.5 | 8.8 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 38.56 | 41.1 | 49.7 | 53.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 718.33 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -1.49 | 18.9 | -4.9 | -4.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -26.24 | -63.4 | 333.4 | 244.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -1.49 | 18.9 | -4.9 | -4.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 38.56 | 41.1 | 49.7 | 53.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 197.93 | 520.3 | 572.6 | 511.6 | ||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 716.06 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.operating-income | 518.13 | 512.4 | 476.7 | 425.6 | ||||||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 516.64 | 531.3 | 471.8 | 421.2 | ||||||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 19.18 | 26.6 | 45.5 | 59.2 | ||||||||||||||||||||||||||||||
income-statement-row.row.net-income | 486.79 | 496.5 | 411.1 | 348.5 |
Pogosto zastavljeno vprašanje
Kaj je Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) skupna sredstva?
Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) skupna sredstva so 8354338037.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so 4064436167.000.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.278.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 0.245.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.061.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.065.
Kaj je Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 496512201.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 1874155569.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 1696039196.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 922054214.000.